Advertisement

Combined Laser and Anti-VEGF Treatment for Zone I ROP

  • Ulrich Spandau
  • Sang Jin Kim
Chapter

Abstract

ROP in zone I is very difficult to treat. The conventional treatment modality of laser coagulation results in many recurrences and complications. The author describes very elegant how this problem was approached and solved at his hospital in Korea.

Keywords

Recurrence of ROP Zone I Laser coagulation 

References

  1. 1.
    Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364:603–15.CrossRefGoogle Scholar
  2. 2.
    Geloneck MM, Chuang AZ, Clark WL, Hunt MG, Norman AA, Packwood EA, Tawansy KA, Mintz-Hittner HA, BEAT-ROP Cooperative Group. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol. 2014;132:1327–33.CrossRefGoogle Scholar
  3. 3.
    Kim J, Kim SJ, Chang YS, Park WS. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Retina. 2014;34:77–82.CrossRefGoogle Scholar
  4. 4.
    Yoon JM, Shin DH, Kim SJ, Ham DI, Kang SW, Chang YS, Park WS. Outcomes after laser versus combined laser and Bevacizumab treatment for Type 1 retinopathy of prematurity in zone I. Retina. 2017;37:88–96.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ulrich Spandau
    • 1
  • Sang Jin Kim
    • 2
  1. 1.OphthalmologyUniversity of Uppsala OphthalmologyUppsalaSweden
  2. 2.Department of OphthalmologySamsung Medical Center, Sungkyunkwan UniversitySeoulSouth Korea

Personalised recommendations